Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2697-2702

  Hamel, Wolfgang ^a   Magnelli, Lucia ^b   Chiarugi, Vincenzo P ^b   Israel, Mark A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL DEATH; CELL JUNCTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; HERPES; HERPES SIMPLEX VIRUS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

3T3 CELLS; ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CELL COMMUNICATION; DNA, NEOPLASM; FLUORESCEINS; FLUORESCENT DYES; GANCICLOVIR; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GLIOMA; HUMANS; MICE; PHAGOCYTOSIS; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0029997766     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Moolten, F L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1. 279-287, 1994.
2. Mullen, C. A Metabolic suicide genes in gene therapy. Pharmacol Ther., 63: 199-207, 1994.
3. Deonarain, M. P., Spooner, R. A., and Epenetos, A A. Genetic delivery of enzymes for cancer therapy. Gene Ther., 2. 235-244, 1995.
4. r-deoxyuridine and related compounds. FEBS Lett., 185: 95-100, 1985.
5. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
6. Culver, K W , Ram, Z., Wallbridge, S , Ishii, H., Oldfield, E H , and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science (Washington DC), 256: 1550-1552, 1992
7. Freeman, S M., Abboud, C. N., Whartenby, K. A., Packman, C. H , Koeplin, D S , Moolten, F L , and Abraham, G. N The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
8. Takamiya, Y., Short, M. P., Ezzeddine, Z. D., Moolten, F. L., Breakefield, X. O., and Martuza, R L. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidme kinase gene and wild type retrovirus kills other tumor cells J. Neurosci Res., 33: 493-503, 1992
9. Samejima, Y., and Meruelo, D. Bystander killing induces apoptosis and is inhibited by forskolin. Gene Ther., 2. 50-58, 1995
10. Kaneko, Y., and Tsukamoto, A Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir. Cancer Lett., 96: 105-110, 1995
11. Fick, J., Barker, F. G., II., Dazin, P., Westphale, E. M. Beyer, E. C. and Israel, M. A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro Proc Natl. Acad. Sci. USA, 92: 11071-11075, 1995
12. Elshami, A. A., Saavedra, A , Zhang, H , Kucharczuk, J. C., Spray, D. C., Fishman, G. I., Amin, K. M., Kaiser, L. R., and Albelda, S. M. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther., 3: 85-92, 1996
13. Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., and Yamasaki, H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA, 93: 1831-1835, 1996.
14. Colombo, B M., Benedetti, S., Ottolenghi, S., Mora, M., Pollo, B., Poli, G., and Finocchiaro, G The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6. 763-772, 1995
15. Miller, A D., and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6: 2895-2902, 1986.
16. Magnelli, L., Cinelli, M., Turchetti, A., and Chiarugi, V. P. Bcl-2 overexpression abolishes early calcium waving preceding apoptosis in NIH-3T3 murine fibroblasts. Biochem Biophys. Res Commun., 204, 84-90, 1994
17. Zhang, Y. Z., Olson, N., Mao, F., Roth, B., and Haugland, R. P. New fluorescent probes for long-term tracing of living cells. FASEB J., 6: A1835, 1992.
18. Gorczyca, W , Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993.
19. Zar, J. H. Biostatistical Analysis, Ed 2, pp. 162-205. Englewood Cliffs, NJ, Prentice-Hall, 1984
20. Chen, C-Y., Chang, Y-N., Ryan, P , Linscott, M., McGarrity, G. J , and Chiang, Y. L. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect." Hum. Gene Ther. 6: 1467-1476, 1995
21. Tapscott, S. J , Miller, A D , Olson, J. M., Berger, M. S., Groudine, M., and Spence, A. M Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. USA, 91: 8185-8189, 1994
22. Kerr, J. F., Winterford, C M , and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer (Phila), 73: 2013-2026, 1994.
23. Hu, Z. B., Minden, M. D., and McCulloch, E. A. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells. Leukemia (Baltimore), 9. 1667-1673, 1995
24. Kim, J H., Kim, S H., Kolozsvary, A., Brown, S. L., Kim, O. B., and Freytag, S. O. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. Int. J. Radiat Oncol. Biol. Phys., 33. 861-868, 1995.
25. Korsmeyer, S J. Regulators of cell death. Trends Genet., 11: 101-105, 1995